Insulin resistance and inflammation markers in myocardial infarction

Journal of Inflammation Research

Volumn 6, Issue 1, 2013, Pages 83-90

  Gruzdeva, Olga ^a   Uchasova, Evgenya ^a   Dyleva, Yulia ^a   Belik, Ekaterina ^a   Shurygina, Ekaterina ^a   Barbarash, Olga ^a  

^a RESEARCH INSTITUTE FOR COMPLEX ISSUES OF CARDIOVASCULAR DISEASES   (Russian Federation)

Author keywords

Inflammation; Insulin resistance; Myocardial infarction; Type 2 diabetes mellitus

Indexed keywords

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; C PEPTIDE; C REACTIVE PROTEIN; CALCIUM CHANNEL BLOCKING AGENT; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; FATTY ACID; GLUCOSE; HEPARIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INSULIN; INTERLEUKIN 6; NITRIC ACID DERIVATIVE; PLASMINOGEN ACTIVATOR INHIBITOR 1;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GLUCOSE BLOOD LEVEL; HEART INFARCTION; HOSPITALIZATION; HUMAN; INFLAMMATION; INSULIN RESISTANCE; INSULIN SENSITIVITY; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL;

EID: 84879129514     PISSN: None     EISSN: 11787031     Source Type: Journal    
DOI: 10.2147/JIR.S43081     Document Type: Article

References (22)

1. Pickup J. Infammation and activated innate immunity in the pathogenesis of type 2 diabetes. Diabetes Care. 2004;27:813-823.
2. Yu Q, Gao F, Ma XL. Insulin says NO to cardiovascular disease. Cardiovasc Res. 2011;89:516-524.
3. Fernández JM, Rilcart W. Insulin resistance and chronic cardiovascular infammatory syndrome. Endocr Rev. 2003;24:278-301.
4. Smit JW, Romijn JA. Acute insulin resistance in myocardial ischemia: causes and consequences. Semin Cardiothorac Vasc Anesth. 2006;10: 215-219.
5. Antoinette M, Steffen L, Jacobs D, et al. Relation of C-reactive protein to insulin resistance and cardiovascular risk factors in youth. Diabetes Care. 2005;28:1763-1768.
6. Barrett TD, Hennan JK, Marks RM, Lucchesi BR. C-reactive-protein-associated increase in myocardial infarct size after ischemia/reperfusion. J Pharmacol Exp Ther. 2002;303:1007-1013.
7. Fernandez-Real JM, Vayreda M, Richart C, et al. Circulating interleukin 6 levels, blood pressure, and insulin sensitivity in apparently healthy men and women. J Clin Endocrinol Metab. 2001;86:1154-1159.
8. Geiger PC, Hancock C, Wright DC, Han DH, Holloszy JO. IL-6 increases muscle insulin sensitivity only at superphysiological levels. Am J Physiol Endocrinol Metab. 2007;292:1842-1846.
9. Frangogiannis NG, Smith CW, Entman ML. The infammatory response in myocardial infarction. Cardiovasc Res. 2002;53:31-47.
10. Collet JP, Montalescot G, Vicaut E, et al. Acute release of plasminogen activator inhibitor-1 in ST-segment elevation myocardial infarction predicts mortality. Circulation. 2003;108:391-394.
11. Alessi MC, Juhan-Vague I. PAI-1 and the metabolic syndrome. Arterioscler Thromb Vasc Biol. 2006;26:2200-2207.
12. Juhan-Vague I, Morange PE, Frere C, et al. The plasminogen activator inhibitor-1 -675 4G/5G genotype influences the risk of myocardial infarction associated with elevated plasma proinsulin/insulin levels in men from Europe: the HIFMECH study. J Thromb Haemost. 2003;1: 2322-2329.
13. Kryzhanovsky VA. Diagnosis and treatment of myocardial infarction. K.: Phoenix; 2001.
14. Katz A, Nambi SS, Mather K, et al. Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans. J Clin Endocrinol Metab. 2000;85:2402-2410.
15. Leclercq IA, Da Silva Morais A, Schroyen B, Van Hul N, Geerts A. Insulin resistance in hepatocytes and sinusoidal liver cells: mechanisms and consequences. J Hepatol. 2007;47:142-156.
16. Cefalu WT. Insulin resistance: cellular and clinical concepts. Exp Biol Med (Maywood). 2001;226:13-26.
17. Papanicolaou DA, Vgontzas AN. Interleukin-6: the endocrine cytokine. J Clin Endocrinol Metab. 2000;85:1331-1333.
18. Nieto-Vazquez I, Fernández-Veledo S, de Alvaro C, Lorenzo M. Dual role of interleukin-6 in regulating insulin sensitivity in murine skeletal muscle. Diabetes. 2008;57:3211-3221.
19. Opie LH, Knuuti J. The adrenergic-fatty acid load in heat failure. J Am Coll Cardiol. 2009;54:1637-1646.
20. Gwechenberger M, Mendoza LH, Youker KA, et al. Cardiac myocytes produce interleukin-6 in culture and in viable border zone of reperfused infarctions circulation. Circulation. 1999;99:546-551.
21. Pravenec M, Kajiya T, Zídek V, et al. Effects of human C-reactive protein on pathogenesis of features of the metabolic syndrome. Hypertension. 2011;57:731-737.
22. 612 in L6 myocytes, thereby impairing the insulin signalling pathway that promotes glucose transport. Diabetologia. 2007;50:840-849.